RxDoctor Payments Data

Lawrence Johnson, MD

Orthopaedic Surgery of the Spine · North Chelmsford, MANPI 1225003049

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (46.8%), food and beverage and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Stryker at 56.1% of the total. Reporting peaked in 2019 at $1,857 and has fallen 81.1% since, to $350 in 2025. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in MA, where the typical reported total is $21,142.

$5,820in general payments, 2019–2025

Across 78 payments — averaging $74.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Kairos Surgical Inc$1K
  • Medtronic$283
  • Pfizer$213
  • Vertex$113
  • Acumed LLC$89
  • plus $637 from 18 others

What the payments were for

  • Travel & lodging$2,72447%
  • Food & beverage$1,81831%
  • Education$1,27922%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,820 in reported general payments places this provider in the 25th percentile of 28 orthopaedic surgery of the spine providers in Massachusetts.

See all orthopaedic surgery of the spine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$97,312
Medicare patients
227
Services billed
11,813

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine25$2,460
Celecoxib95$2,324
Nabumetone127$1,124
Ibuprofen77$921
Gabapentin35$229
Diclofenac Sodium14$163
Oxycodone Hcl22$99
Methylprednisolone18$98

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in North Chelmsford

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →